🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Singapore / NCT07804316
Recruiting Observational

Fostering Self-Empowerment in CKD Patients Through Food Choice Mapping

NCT07804316 · tracked via the Priya Life Science Singapore tracker
Phase
Observational
Started
2026-04-15
Last updated
2026-09-04

Condition(s) studied

CKDChronic Kidney Disease (Stages 3b-5)

Investigational drug(s) / intervention(s)

Mobile application empowerment approach

Mobile application empowerment approach: Participant will be provided access to the prototype mobile application known for this trial. Participants will be required to utilise the mobile application for 12 days (two 6-consecutive days, twice within 3 months) during a 3-month period. During the agreed dates, participant will need to take photos of their food intake and upload them onto the mobile application for evaluation.

Study summary

This project aims to develop mapping of food choices available for chronic kidney disease (CKD) patients when dining out in Singapore. Following the mapping, a mobile application will be developed based on renal dining out food map mobile application (RENDOFOMAP) and trialed on patients with CKD. The specific aims of the project include:

1. Mapping out food choices suitable for patients with CKD when dining out in Singapore which will eventually be translated into a mobile application incorporating simple AI functionality.
2. To evaluate the impact of using RENDOFOMAP on self-empowerment, quality of life, nutritional status, and serum biochemistry in patients with CKD.
3. To evaluate the acceptability and user experience of RENDOFOMAP

Participants with CKD will use the newly developed mobile application to find out if there is improvement in self-empowerment, quality of life, nutritional status, and serum biochemistry.

Eligibility

Sex
ALL
Min age
21 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Are fluent in English. This is necessary to ensure clear communication and understanding of study procedures and materials. * Adequate proficiency in using smartphone i.e. downloading app, taking photo, completing e-forms within the mobile applications. This is essential for participants to effectively use the mobile application being tested. * Diagnosed with CKD Stage 3B-5. This targets the specific patient population that the study aims to benefit. Exclusion Criteria: * Only fluent in languages other than English. This could hinder effective communication and understanding of the study. * Diagnosis of cognitive deficit or neurological disorder. These conditions could impair the ability to follow study procedures or provide reliable data. * Uncontrolled diabetes (HbA1c\>8.5%). This condition could introduce additional health risks and confound study results. * Recent hypoglycemic episodes. This could pose a safety risk during the study. * Newly initiated on dialysis or planning for dialysis within the next 6 months. These patients may have rapidly changing health conditions that could affect study outcomes. * Decompensated liver cirrhosis. This condition could complicate the interpretation of study results. * Pregnant and lactating. These conditions could introduce additional variables that affect study outcomes. * Inability to provide consent. This ensures that all participants can legally and ethically participate in the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Singapore Institute of Technology Singapore Singapore Recruiting

More Singapore Institute of Technology trials in Singapore

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07804316 on ClinicalTrials.gov ↗ ← All trials in Singapore